Skip to main content

Table 2 Preoperative demographic and clinical data of the two study groups of patients who underwent total hip arthroplasty

From: Multimodal perioperative care plus immunonutrition versus traditional care in total hip arthroplasty: a randomized pilot study

Variables

Control Group

ACERTO Group

pa

(n = 17):

(n = 15)

n(%) or Mean ± DP

n(%) or Mean ± DP

Age (years)

58

±17

57

±12

0.92

Sex

     

 Male

8

47 %

8

53 %

0.72

 Female

9

53 %

7

47 %

 

Comorbiditiesb

     

 Yes

10

59 %

12

80 %

0.20

 No

7

41 %

3

20 %

 

Nutritional

     

Assessment

     

 Malnourished

5

29 %

2

13 %

0.40

 Eutrophic

12

71 %

13

87 %

 

Immune supplement

     

 Yes

0

0 %

15

87 %

<0.01

 No

17

100 %

0

13 %

 

Fasting time (h)

9.52

±1.54

2

±0

<0.001

Hb (g/dL)

13.35

±1.10

12.95

±1.39

0.38

CRP (g/L)

10.24

±5.09

10.13

±6.38

0.96

  1. SD standard deviation; n number of patients; VHS velocity of hemo- sedimentation; CRP C-reactive protein; Hb hemoglobin
  2. aChi square, Fisher Exact Test and Wilcoxon t test
  3. bDiabetes mellitus, arterial hypertension, or chronic obstructive pulmonary disease